Brief: Zentalis Pharmaceuticals Q2 EPS USD -1.24
09/08/2024 12:00
Aug 09 (Reuters) - Zentalis Pharmaceuticals Q2 operating expenses USD 65.148 million. * Q2 operating income USD -65.148 million * Q2 pretax profit USD -88.011 million * Q2 net income USD -88.277 million
Recent news on Zentalis Pharmaceuticals
See all newsBrief: Zentalis Pharmaceuticals Says Median Overall Survival Of 15.8 Months With Azenosertib In Cyclin E1-Positive Proc
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer